For most healthcare platforms, buying or licensing AI is significantly faster and cheaper than building in-house. Custom AI builds in healthcare typically require 18 to 36 months and more than $2 million in infrastructure, talent, and compliance costs before reaching production quality.
This guide gives CTOs and product leaders a structured cost analysis covering engineering costs, infrastructure, compliance overhead, time to market, and total cost of ownership, with a clear decision model for when building in-house actually makes sense.
The Build vs Buy Decision in Healthcare AI
The build vs buy AI healthcare question is more complex than it appears. It is not simply a matter of cost and speed. It involves regulatory exposure, clinical risk, and the reality that a model error in a healthcare setting has consequences far beyond a poor user experience.
Four constraints make healthcare AI development uniquely difficult. First, every component touching patient data must operate under a signed BAA and meet HIPAA’s technical safeguards. Second, EHR integration is not optional, as a model that cannot connect to clinical systems has no workflow value. Third, clinical validation is required before production deployment. Fourth, the cost of a false positive or false negative in a clinical AI is a patient safety event, not a correctable recommendation error.
These constraints add cost and time to the build path that organisations consistently underestimate at the outset.
The True Cost of Building AI In-House for Healthcare
Engineering and Data Science Talent Costs
Building a production-grade healthcare AI system requires, at minimum, an ML engineer, a data scientist with clinical NLP experience, a clinical informaticist, and a software engineer for EHR integration. In the US market, this team costs $800,000 to $1.2 million annually in fully loaded salaries.
Healthcare AI talent is scarce and competitive. Hiring timelines are longer than in standard engineering roles, and attrition risk is high when large health systems and well-funded competitors are recruiting from the same talent pool.
Infrastructure and Compute Costs
GPU compute for model training and inference is a high and recurring cost. A production NLP model trained on clinical text requires multiple training runs, with compute costs ranging from $5,000 to $50,000 per run, depending on model size and dataset volume.
HIPAA-compliant cloud infrastructure adds 20 to 40 per cent above standard cloud pricing. Dedicated instances, encrypted storage, audit logging, and VPC configuration for HIPAA workloads are mandatory, not optional. HIPAA-compliant AI infrastructure requirements cannot be retrofitted after the architecture is already built.
Clinical Data and Annotation Costs
Clinical AI models require labelled training data drawn from real patient encounters. Acquiring that data requires de-identification meeting HIPAA’s Safe Harbour standard, annotation by clinical staff who understand medical content, and quality assurance review for consistency.
Annotation costs for clinical NLP tasks typically run $8 to $25 per document. A training dataset of 10,000 annotated clinical notes costs between $80,000 and $250,000 before any model development begins. Healthcare data extraction at the scale required for production model training is itself a significant project.
Compliance and Security Overhead
HIPAA compliance for an in-house AI system requires a formal security risk analysis, encryption across all data paths, audit logging for all PHI access, and a BAA with every cloud vendor in the stack. Third-party platforms absorb these costs as part of their operating overhead. In-house builds must budget for them separately.
SOC 2 Type II certification, which most enterprise health system procurement teams now require, takes 12 months of preparation and costs $30,000 to $80,000 in auditor fees plus internal staff time. AI for healthcare compliance is a standing programme, not a one-time activity.
Time to Production
A realistic build timeline for a production healthcare AI system looks like this:
- Months 1 to 3: data acquisition, de-identification, and annotation infrastructure
- Months 4 to 9: initial model development and internal validation
- Months 10 to 15: EHR integration development and sandbox testing
- Months 16 to 24: clinical validation, compliance review, and staged rollout
- Months 24 to 36: production stabilisation and model iteration
Most organisations that begin an in-house build expecting a 12-month timeline reach the 24-month mark still in pre-production validation. The cost of implementing AI in healthcare at this scale consistently exceeds initial estimates by 40 to 80 per cent.
The True Cost of Buying a Healthcare AI Platform
Licensing and API Pricing Models
Healthcare AI platforms typically price on one of four models: per provider per month, per encounter, annual platform licensing, or API consumption. Per-provider pricing ranges from $200 to $800 per provider per month. Per-encounter pricing ranges from $1 to $8 per processed encounter.
For a group practice with 20 providers seeing 15 patients per day, the annual cost under per-provider pricing ranges from $48,000 to $192,000. Modelling both structures against your specific volume before entering vendor negotiations is essential.
Implementation and Integration Costs
Buying a platform does not eliminate integration costs. EHR configuration, SSO setup, template mapping, sandbox testing, and staff training all require internal IT time and often professional services from the vendor.
For a mid-size health system, implementation costs from a licensed platform typically run $20,000 to $80,000, depending on EHR complexity. This is substantially lower than the engineering time required to build equivalent integration in-house. EHR integration challenges are present in both paths, but a vendor with dozens of prior deployments on the same EHR resolves them significantly faster.
Ongoing Support and Upgrade Costs
Platform vendors handle model updates, regulatory compliance changes, and feature releases as part of the subscription. In-house teams must staff permanently for these activities, which means the build path carries ongoing engineering cost that the buy path converts into a predictable subscription fee.
Budget 10 to 15 per cent of the annual subscription for internal relationship management, configuration updates, and training for new clinical staff. This is substantially lower than the cost of maintaining an in-house model team year over year.
Build vs Buy Healthcare AI: Decision Framework
Factors That Favour Building In-House
Building in-house makes sense in a narrow set of circumstances:
- The organisation has a proprietary clinical dataset representing a genuine competitive advantage, not replicable by vendors
- The use case is highly differentiated and is not served by anything on the market
- An experienced healthcare AI engineering team is already in place
- The organisation has a long-term platform ambition where the AI layer is itself a product sold to others
These conditions apply to a small number of large health systems and established health tech companies. They are rarely met by mid-market organisations or early-stage platforms. Generative AI in healthcare use cases covers the landscape of what is genuinely available off the shelf versus what requires custom development.
Factors That Favour Buying a Platform
Buying a platform is the right choice in the far more common scenario where:
- Speed to market is a priority, and the organisation cannot afford 18 to 36 months of development
- The AI team is small or lacks healthcare-specific NLP experience
- The primary use cases, such as ambient documentation, prior auth automation, or coding support, are well served by existing platforms.
- Compliance infrastructure is not in place,e and building it would divert significant engineering capaci.ty
For most healthcare organisations evaluating automation in healthcare for the first time, the buy path delivers working capability in weeks rather than years, at a fraction of the capital cost.
Total Cost of Ownership Comparison: 3-Year Model
An illustrative 3-year TCO comparison between the two paths for a mid-market platform produces the following ranges.
Built in-house (3-year total):
- Engineering talent: $2.4 million to $3.6 million
- Infrastructure and compute: $300,000 to $600,000
- Clinical data and annotation: $150,000 to $400,000
- Compliance and security: $200,000 to $400,000
- Estimated total: $3.5 million to $7 million
Buy a platform (3-year total):
- Licensing fees: $150,000 to $600,000
- Implementation and integration: $20,000 to $80,000
- Internal management: $60,000 to $150,000
- Estimated total: $230,000 to $830,000
The time to market difference is the largest single factor. An organisation that deploys a licensed platform in three months versus one that completes an in-house build in 24 months has 21 additional months of value from the deployed capability. ROI of AI in healthcare analysis shows that licensed platforms achieve payback within 6 to 12 months, compared to 3 to 5 years for in-house builds.
How Murphi.ai Reduces the Build Burden for Healthcare Platforms
Murphi.ai gives health tech companies and EHR vendors API-first access to production-grade healthcare AI across clinical documentation, RCM automation, prior auth, and coding workflows, without requiring the partner to build or maintain the underlying AI infrastructure.
The core value for organisations evaluating the custom AI vs AI platform decision is:
- Production-ready ambient documentation, coding AI, and RCM automation available via API within weeks
- HIPAA compliance infrastructure, including BAA and SOC 2 Type II certification, is handled at the platform level
- EHR integration with Epic, eClinicalWorks, Athenahealth, PointClickCare, and MatrixCare is already built and certified
- Continuous model updates and compliance changes managed by Murphi’s engineering team without any partner action required
For companies that want to surface Murphi’s capabilities under their own brand, the white-label automation model provides full API access with no Murphi branding in the end-user experience. This is the fastest path to a production AI-powered healthcare product with the lowest capital commitment.
FAQs About Build vs Buy AI for Healthcare
How much does it cost to build a healthcare AI system from scratch?
A production-ready healthcare AI system typically costs $2 million to $5 million over three years, covering engineering talent, clinical data annotation, HIPAA-compliant infrastructure, and compliance certification. Most organisations exceed their initial budget by 40 to 80 per cent due to underestimated data and compliance costs.
What is the typical timeline to build clinical AI in-house?
Most in-house healthcare AI builds take 18 to 36 months from start to production deployment. EHR integration, clinical validation, and compliance review each add months that are rarely accounted for in initial plans. Organisations planning for 12 months consistently reach month 24 still in pre-production testing.
When does it make sense to build AI rather than buy a platform?
Building in-house makes sense when the organisation has proprietary clinical data representing a genuine competitive advantage, a highly differentiated use case that no existing platform serves, and an experienced healthcare AI engineering team already in place. These conditions apply to very few mid-market organisations.
What hidden costs do healthcare organisations underestimate when building AI?
The most underestimated costs are clinical data annotation, SOC 2 Type II certification, ongoing model maintenance after deployment, and the revenue impact of delayed time to market. Compliance infrastructure alone typically costs $200,000 to $400,000 over three years and is frequently excluded from initial build estimates.
How do healthcare AI platform licensing costs compare to in-house build costs?
A licensed platform costs $230,000 to $830,000 over three years for a mid-market deployment. An equivalent in-house build costs $3.5 million to $7 million over the same period. The difference is driven primarily by the elimination of engineering talent costs and the compression of time to market from years to weeks.